Improved mobilization of the CD34 + and CD133 + bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease

Stem Cells and Development

Volumn 20, Issue 9, 2011, Pages 1491-1501

  Turan, Ramazan Gökmen ^a   Bozdag Turan, Ilkay ^a   Ortak, Jasmin ^a   Akin, Ibrahim ^a   Kische, Stephan ^a   Schneider, Henrik ^a   Turan, Cem Hakan ^a   Rehders, Tim Christopher ^a   Rauchhaus, Mathias ^a   Kleinfeldt, Tilo ^a   Adolph, Ester ^a   Brehm, Micheal ^b   Yokus, Sedat ^b   Steiner, Stephan ^b   Sahin, Kurtulus ^c   Nienaber, Christoph A ^a   Ince, Hüseyin ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c Institute for Clinical Research and Statistics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HEART EJECTION FRACTION; HEART INFARCTION SIZE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; INTRACORONARY BONE MARROW CELL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; PRIORITY JOURNAL;

AGED; ANTIGENS, CD; ANTIGENS, CD34; BONE MARROW TRANSPLANTATION; FEMALE; GLYCOPROTEINS; HEART; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PEPTIDES; POINT-OF-CARE SYSTEMS; STEM CELLS; STROKE VOLUME; TRANSPLANTATION, AUTOLOGOUS; VENTRICULAR FUNCTION, LEFT;

EID: 80052325733     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2010.0373     Document Type: Article

References (52)

1. Asahara T, T Murohara, A Sullivan, M Silver, R van der Zee, T Li, B Witzenbichler, G Schatteman and JM Isner. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967.
2. Kalka C, H Masuda, T Takahashi, WM Kalka-Moll, M Silver, M Kearney, T Li, JM Isner and T Asahara. (2000). Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97:3422-3427.
3. Rafii S and D Lyden. (2003). Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9:702-712.
4. Peichev M, AJ Naiyer, D Pereira, Z Zhu, WJ Lane, M Williams, MC Oz, DJ Hicklin, L Witte, MA Moore and S Rafii. (2000). Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 95:952-958.
5. Yin AH, S Miraglia, ED Zanjani, G Almeida-Porada, M Ogawa, AG Leary, J Olweus, J Kearney and DW Buck. (1997). AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90:5002-5012.
6. Gunsilius E, HC Duba, AL Petzer, CM Kahler and GA Gasti. (2001). Contribution of endothelial cells of hematopoietic origin to blood vessel formation. Circ Res 88:E1.
7. Kong D, LG Melo, M Gnecchi, L Zhang, G Mostosiavsky, CC Liew, RE Pratt and VJ Dzau. (2004). Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 110:2039-2046.
8. Walter DH, K Rittig, FH Bahlmann, R Kirchmair, M Silver, T Murayama, H Nishimura, DW Losordo, T Asahara and JM Isner. (2002). Statin therapy accelerates reendothelialization: A novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105:3017-3024.
9. Werner N, S Junk, U Laufs, A Link, K Walenta, M Bohm and G Nickenig. (2003). Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93:e17-e24.
10. Werner N, J Priller, U Laufs, M Endres, M Böhm, U Dirnagl and G Nickenig. (2002). Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: Effect of 3-hydroxy-3- methylglutaryl coenzyme A reductase inhibition. Arterioscler Thromb Vasc Biol 22:1567-1572.
11. Sondergaard CS, J Bonde, F Dagnaes-Hansen, JM Nielsen, V Zachar, M Holm, P Hokland and L Pedersen. (2009). Minimal engraftment of human CD34+ cells mobilized from healthy donors in the infarcted heart of athymic nude rats. Stem Cells Dev 18:845-856.
12. Strauer BE, M Brehm, T Zeus, M Köstering, A Hernandez, RV Sorg, G Kögler and P Wernet. (2002). Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106:1913-1918.
13. Assmus B, V Schachinger, C Teupe, M Britten, R Lehmann, N Döbert, F Griinwald, A Aicher, C Urbich, H Martin, D Hoelzer, S Dimmeler and AM Zeiher. (2002). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106:3009-3017.
14. Wollert KC, GP Meyer, J Lotz, S Ringes-Lichtenberg, P Lippolt, C Breidenbach, S Fichtner, T Korte, B Hornig, D Messinger, L Arseniev, B Hertenstein, A Ganser and H Drexler. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 364:141-148.
15. Janssens S, C Dubois, J Bogaert, K Theunissen, C Deroose, W Desmet, M Kalantzi, L Herbots, P Sinnaeve, J Dens, J Maertens, F Rademakers, S Dymarkowski, O Gheysens, J Van Cleemput, G Bormans, J Nuyts, A Belmans, L Mortelmans, M Boogaerts and F Van de Werf. (2006). Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomised controlled trial. Lancet 367:113-121.
16. Schachinger V, S Erbs, A Elsasser, W Haberbosch, R Hambrecht, H Hölschermann, J Yu, R Corti, DG Mathey, CW Hamm, T Süselbeck, B Assmus, T Tonn, S Dimmeler and AM Zeiher. (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355:1210-1221.
17. Strauer BE and R Kornowski. (2003). Stem cell therapy in perspective. Circulation 107:929-934.
18. Sheehan FH, EL Bolson, HT Dodge, DG Mathey, J Schofer and HW Woo. (1986). Advantages and applications of the centreline method for characterizing regional ventricular function. Circulation 74:293-305.
19. Keeney M, I Chin-Yee, K Weir, J Popma, R Nayar and DR Sutherland. (1998). Single platform flow cytometric absolute CD34+ cell counts based o the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry 15:61-70.
20. Sutherland DR, L Anderson, M Keeney, R Nayar and I Chin- Yee. (1996). The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother 5:213-226.
21. Dimmeler S and AM Zeiher. (2009). Cell therapy of acute myocardial infarction: Open questions. Cardiology 113: 155-160.
22. Dimmeler S, AM Zeiher and MD Schneider. (2005). Unchain my heart: The scientific foundations of cardiac repair. J Clin Invest 115:572-583.
23. Assmus B, J Honold, V Schächinger, MB Britten, U Fischer- Rasokat, R Lehmann, C Teupe, K Pistorius, H Martin, ND Abolmaali, T Tonn, S Dimmeler and AM Zeiher. (2006). Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355:1222-1232.
24. Strauer BE, M Brehm, T Zeus, T Bartsch, C Schannwell, C Antke, RV Sorg, G Kögler, P Wernet, HW Muller and M Köstering. (2005). Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease (The IACT Study). J Am Coll Cardiol 46:1651-1658.
25. Hermann PC, SL Huber, T Herrler, C von Hesler, J Andrassy, SV Kevy, MS Jacobson and C Heeschen. (2008). Concentration of bone marrow total nucleated cells by a point-of-care device provides a high yield and preserves their functional activity. Cell Transplant 16:1059-1069.
26. Iba O, H Matsubara, Y Nozawa, S Fujiyama, K Amano, Y Mori, H Kojima and T Iwasaka. (2002). Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 106:2019-2025.
27. Massberg S, I Konrad, K Schürzinger, M Lorenz, S Schneider, D Zohlnhoefer, K Hoppe, M Schiemann, E Kennerknecht, S Sauer, C Schulz, SH Kerstan, M Peluso, P Goyal, D Vestweber, NR Emambokus, DH Busch, J Frampton and M Gawaz. (2006). Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med 203:1221-1233.
28. Orlic D, J Kajstura, S Chimenti, I Jakoniuk, SM Anderson, B Li, J Pickel, R McKay, B Nadal-Ginard, DM Bodine, A Leri and P Anversa. (2001). Bone marrow cells regenerate infarcted myocardium. Nature 410:701-705.
29. Murry CE, MH Soonpaa, H Reinecke, H Nakajima, HO Nakajima, M Rubart, KB Pasumarthi, JI Virag, SH Bartelmez, V Poppa, G Bradford, JD Dowell, DA Williams and LJ Field. (2004). Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428:664-668.
30. Balsam LB, AJ Wagers, JL Christensen, T Kofidis, IL Weissman and RC Robbins. (2004). Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428:668-673.
31. Dimmeler S, J Burchfield and AM Zeiher. (2008). Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol 28:208-216.
32. Lipinski MJ, GGL Biondi-Zoccai, A Abbate, R Khianey, I Scheiban, J Bartunek, M Vanderheyden, HS Kim, HJ Kang, BE Strauer and GW Vetrovec. (2007). Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction. J Am Coll Cardiol 50:1761-1767.
33. Sharma R and R Raghubir. (2007). Stem cell therapy: A hope for dying hearts. Stem Cells Dev 16:517-536.
34. Jiang Y, BN Jahagirdar, RL Reinhardt, CD Schwartz, CD Keene, XR Ortiz-Gonzalez, M Reyes, T Lenvik, T Lund, M Blackstad, J Du, S Aldrich, A Lisberg, WC Low, DA Largaespada and CM Verfaillie. (2007). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 447:879-880.
35. Asahara T, H Masuda, T Takahashi, C Kalka, C Pastore, M Silver, M Kearne, M Magner and JM Isner. (1999). Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221-228.
36. Turan RG, M Brehm, M Koestering, T Zeus, T Bartsch, S Steiner, F Picard, P Ebner, CM Schannwell and BE Strauer. (2007). Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction. Eur J Clin Invest 37:842-851.
37. Blau HM, TR Brazelton and JM Weimann. (2001). The evolving concept of a stem cell: Entity or function? Cell 105:829-841.
38. Walter DH, J Haendeler, J Reinbold, U Rochwalsky, F Seeger, J Honold, J Hoffmann, C Urbich, R Lehmann, F Arenzana-Seisdesdos, A Aicher, C Heeschen, S Fichtlscherer, AM Zeiher and S Dimmeler. (2005). Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 97:1142-1151.
39. Stellos K and M Gawaz. (2007). Platelet interaction with progenitor cells: Potential implications for regenerative medicine. Thromb Haemost 98:922-931.
40. Hill JM, G Zalos, JP Halcox, WH Schenke, MA Waclawiw, AA Quyyumi and T Finkel. (2003). Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593-600.
41. Urbich C and S Dimmeler. (2004). Endothelial progenitor cell: Characterization and role in vascular biology. Circ Res 95:343-353.
42. Werner N, S Kosiol, T Schiegl, P Ahlers, K Walenta, A Link, M Bohm and G Nickenig. (2005). Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353:999-1007.
43. Schächinger V, S Erbs, A Elsässer, W Haberbosch, R Hambrecht, H Hölschermann, J Yu, R Corti, DG Mathey, CW Hamm, T Süselbeck, B Assmus, T Tonn, S Dimmeler and AM Zeiher. (2006). Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: Final 1-year results of the REPAIR-AMI trial. Eur Heart J 27: 2775-2783.
44. Agnoletti L, S Curello, T Bachetti, F Malacarne, G Gaia, L Comini, M Volterrani, P Bonetti, G Parrinello, M Cadei, PG Grigolato and R Ferrari. (1999). Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: Role of tumor necrosis factor-alpha. Circulation 100:1983-1991.
45. Katz SD, T Khan, GA Zeballos, L Mathew, P Potharlanka, M Knecht and J Whelan. (1999). Decreased activity of the L-arginine-nitric-oxide metabolic pathway in patients with congestive heart failure. Circulation 99:2113-2117.
46. Aicher A, C Heeschen, C Mildner-Rihm, C Urbich, C Ihling, K Technau-Ihling, AM Zeiher and S Dimmeler. (2003). Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9:1370-1376.
47. Takahashi T, C Kalka, H Masuda, D Chen, M Silver, M Kearney, M Magner, JM Isner and T Asahara. (1999). Ischemia- and cytokine-induced mobilization of bone marrow- derived endothelial progenitor cells for neovascularization. Nat Med 5:434-438.
48. Brehm M, F Picard, P Ebner, G Turan, E Bölke, M Köstering, P Schüller, T Fleissner, D Ilousis, K Augusta, M Peiper, CH Schannwell and BE Strauer. (2009). Effects of exercise training on mobilization and functional activity of bloodderived progenitor cells in patients with acute myocardial infarction. Eur J Med Res 14:393-405.
49. Laufs U, N Werner, A Link, M Endres, S Wassmann, K Jurgens, E Miche, M Böhm and G Nickenig. (2004). Physical training increases endothelial progenitor cell, inhibits neointima formation, and enhances angiogenesis. Circulation 109:220-226.
50. Candipan RC, BY Wang, R Bultrago, PS Tsao and JP Cooke. (1996). Regression or progression. Dependency on vascular nitric oxide. Arterioscler Thromb Vasc Biol 16:44-50.
51. Coke JP, AH Singer, P Tsao, P Zera, RA Rowan and ME Billingham. (1992). Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 90:1168-1172.
52. Bassaneze V, VG Barauna, C Lavini-Ramos, J Kalil, IT Schettert, AA Miyakawa and JE Krieger. (2010). Shear stress induces nitric oxide-mediated vascular endothelial growth factor production in human adipose tissue mesenchymal stem cells. Stem Cells and Development 19: 371-378.